Company Analysis
Sign in

Pfizer Inc. (PFE)

NYSE: PFE · Pharmaceutical Preparations · New York, NY · filing with the SEC since 1994
Full chart Alerts Compare
Grade5.9
◀ Past 6.7● Present 6.7▶ Future 4.1
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

11,714 patents granted to the 66 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Pfizer Inc.’s names, not what it holds today.

Patents granted
11,714
11,353 utility, 307 design, 52 reissue, 2 statutory invention registration, 1976 to Dec 31, 2025
Granted in 2025
73
Against 84 in 2024 and 105 in 2023
Applications published
7,023
122 of them in 2025
Names they are printed under
66
its own name, a subsidiary
By yearGrantedApplications published
'11'12'13'14'15'16'17'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals306
Organic fine chemistry105
Biotechnology40
Measurement4
Analysis of biological materials2
Medical technology2
Chemical engineering1
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name66 counted
Pfizer Inc. its own name
US, as the owner printed on each patent. 123 more under the same name are not counted (printed in GB)
4,416 granted
2,300 published
Wyeth, LLC a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in DE)
1,448 granted
1,961 published
WARNER-LAMBERT COMPANY LLC a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in FR)
2,583 granted
110 published
Pharmacia & Upjohn Company LLC a subsidiary
US, as the owner printed on each patent. 54 more under the same name are not counted (printed in SE, printed in IT)
548 granted
139 published
Array BioPharma, Inc. a subsidiary
US, as the owner printed on each patent
329 granted
235 published
Genetics Institute, LLC a subsidiary
US, as the owner printed on each patent. 22 more under the same name are not counted (printed in GB)
397 granted
76 published
Pfizer Inc. its own name
named as the applicant on its applications, in US. 29 more under the same name are not counted (printed in GB)
0 granted
428 published
Pharmacia Corporation a subsidiary
US, as the owner printed on each patent. 27 more under the same name are not counted (printed in SE, printed in DE)
210 granted
203 published
ARENA PHARMACEUTICALS, INC. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in CA)
219 granted
154 published
Agouron Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
187 granted
114 published
John Wyeth & Brother Limited a subsidiary
GB, as the owner printed on each patent. 2 more under the same name are not counted (printed in US)
298 granted
0 published
Sugen, Inc. a subsidiary
US, as the owner printed on each patent
158 granted
101 published
HOSPIRA, INC. a subsidiary
US, as the owner printed on each patent
133 granted
107 published
A. H. Robins Company, Incorporated a subsidiary
US, as the owner printed on each patent
220 granted
0 published
Array BioPharma Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
147 published
Arena Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
140 published
Anacor Pharmaceuticals, LLC a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in CA)
69 granted
63 published
SEAGEN INC. a subsidiary
US, as the owner printed on each patent
65 granted
62 published
Medivation Technologies LLC a subsidiary
US, as the owner printed on each patent
63 granted
42 published
Seagen Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
100 published
Global Blood Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
86 published
RINAT NEUROSCIENCE CORP. a subsidiary
US, as the owner printed on each patent. 1 more under the same name are not counted (printed in CA)
42 granted
41 published
GLOBAL BLOOD THERAPEUTICS, INC. a subsidiary
US, as the owner printed on each patent
57 granted
21 published
Wyeth LLC a subsidiary
named as the applicant on its applications, in US
0 granted
73 published
Parke, Davis & Company a subsidiary
US, as the owner printed on each patent. 2 more under the same name are not counted (printed in GB)
63 granted
0 published
TRILLIUM THERAPEUTICS INC. a subsidiary
CA, as the owner printed on each patent. 1 more under the same name are not counted (printed in DE)
28 granted
25 published
Shiley Incorporated a subsidiary
US, as the owner printed on each patent
52 granted
0 published
Anacor Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
48 published
Pfizer Italia S.R.L. a subsidiary
IT, as the owner printed on each patent
23 granted
12 published
King Pharmaceuticals Research and Development, Inc a subsidiary
US, as the owner printed on each patent
28 granted
5 published
Alpharma Pharmaceuticals LLC a subsidiary
US, as the owner printed on each patent
9 granted
18 published
Medivation Technologies, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
25 published
Arixa Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
9 granted
10 published
Pfizer Products Inc. a subsidiary
US, as the owner printed on each patent
5 granted
14 published
Medivation Prostate Therapeutics LLC a subsidiary
US, as the owner printed on each patent
12 granted
6 published
Medivation Prostate Therapeutics LLC a subsidiary
named as the applicant on its applications, in US
0 granted
17 published
Warner-Lambert Company LLC a subsidiary
named as the applicant on its applications, in US
0 granted
15 published
Encysive Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
9 granted
5 published
RINAT NEUROSCIENCE CORP. a subsidiary
named as the applicant on its applications, in US
0 granted
14 published
Alpharma Pharmaceuticals LLC a subsidiary
named as the applicant on its applications, in US
0 granted
11 published
Hospira, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
11 published
InnoPharma, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
11 published
FoldRx Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
3 granted
7 published
HOSPIRA AUSTRALIA PTY LTD a subsidiary
AU, as the owner printed on each patent
4 granted
6 published
Pfizer Health AB a subsidiary
SE, as the owner printed on each patent
7 granted
2 published
Trillium Therapeutics Inc. a subsidiary
named as the applicant on its applications, in CA
0 granted
9 published
AMPLYX PHARMACEUTICALS, INC. a subsidiary
US, as the owner printed on each patent
3 granted
5 published
PEAK ENTERPRISES, INC. a subsidiary
US, as the owner printed on each patent
6 granted
1 published
Wyeth Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
3 granted
3 published
ARIXA PHARMACEUTICALS, INC. a subsidiary
named as the applicant on its applications, in US
0 granted
5 published
Bamboo Therapeutics, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
5 published
Medivation Neurology, Inc. a subsidiary
US, as the owner printed on each patent
0 granted
5 published
Pharmacia & Upjohn Company, a Delaware corporation a subsidiary
US, as the owner printed on each patent
0 granted
5 published
Wyeth Holdings LLC a subsidiary
named as the applicant on its applications, in US
0 granted
5 published
Ignite Immunotherapy, Inc. a subsidiary
US, as the owner printed on each patent
2 granted
2 published
Amplyx Pharmaceuticals, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
3 published
Bamboo Therapeutics, Inc. a subsidiary
US, as the owner printed on each patent
3 granted
0 published
King Pharmaceuticals, Inc. a subsidiary
US, as the owner printed on each patent
1 granted
2 published
Wyeth, a Delaware corporation a subsidiary
US, as the owner printed on each patent
0 granted
3 published
COLEY PHARMACEUTICAL GROUP INC. a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Ignite Immunotherapy, Inc. a subsidiary
named as the applicant on its applications, in US
0 granted
1 published
Pfizer Japan, Inc. a subsidiary
JP, as the owner printed on each patent
1 granted
0 published
Pfizer R&D UK Limited a subsidiary
named as the applicant on its applications, in GB
0 granted
1 published
Pharmacia & Upjohn Company, a corporation of the State of Delaware a subsidiary
US, as the owner printed on each patent
0 granted
1 published
Vicuron Holdings LLC a subsidiary
US, as the owner printed on each patent
1 granted
0 published
Wyeth Farma, S.A. a subsidiary
ES, as the owner printed on each patent
0 granted
1 published
Names not counted (17)
Pharmacia Limited
Most of its patents print SE; this name counts in GB, US. 185 granted and 6 published under it are not counted.
Pharmacia & Upjohn Company LLC
Most of its patents print IT; this name counts in US. 100 granted and 5 published under it are not counted.
Pharmacia & Upjohn Company LLC
Most of its patents print SE; this name counts in US. 74 granted and 2 published under it are not counted.
Biohaven Pharmaceutical Holding Company Limited
Most of its patents print US; this name counts in VG. 0 granted and 22 published under it are not counted.
Pharmacia Limited
Most of its patents print IT; this name counts in GB, US. 21 granted and 0 published under it are not counted.
Medivation LLC
Most of its patents print CH; this name counts in US. 4 granted and 7 published under it are not counted.
Biohaven Pharmaceutical Holding Company Limited
Most of its patents print US; this name counts in VG. 8 granted and 1 published under it are not counted.
Medivation LLC
Most of its patents print CH; this name counts in US. 0 granted and 6 published under it are not counted.
Pharmacia Limited
Most of its patents print DK; this name counts in GB, US. 2 granted and 0 published under it are not counted.
Warner-Lambert Company GmbH
Most of its patents print JP; this name counts in CH, US. 2 granted and 0 published under it are not counted.
AHP Manufacturing B.V.
Most of its patents print US; this name counts in NL. 0 granted and 1 published under it are not counted.
Arena Pharmaceuticals, Inc.
No country is printed for it. 0 granted and 1 published under it are not counted.
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Dec 23, 202512,502,357Formulations of enzalutamidePharmaceuticalsMedivation Prostate Therapeutics LLC
Dec 16, 202512,496,353Synergistic effects between auristatin-based antibody drug conjugates and inhibitors of the PI3K-AKT mTOR pathwayPharmaceuticalsSEAGEN INC.
Dec 2, 202512,485,157Method of treating COVID-19PharmaceuticalsPfizer Inc.
Nov 18, 202512,473,277Solid forms of a modulator of hemoglobinPharmaceuticalsGLOBAL BLOOD THERAPEUTICS, INC.
Nov 18, 202512,472,180Combinations for treatment of NAFLD/NASH and related diseasesPharmaceuticalsPfizer Inc.
Nov 11, 202512,466,803BCKDK inhibitors and/or degradersPharmaceuticalsPfizer Inc.
Nov 11, 202512,465,593Pharmaceutical compositionPharmaceuticalsArray BioPharma, Inc.
Nov 4, 202512,458,689Escherichia coli compositions and methods thereofPharmaceuticalsPfizer Inc.
Oct 21, 202512,448,439Interferon beta antibodies and uses thereofPharmaceuticalsPfizer Inc.
Oct 21, 202512,447,207Human cytomegalovirus gB polypeptideBiotechnologyPfizer Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Dec 25, 20252025/0387764COAXIAL FLOW DEVICE FOR NANOPARTICLE PREPARATION AND MANUFACTURING EQUIPMENT INCLUDING SUCH DEVICEChemical engineeringPfizer Inc.
Dec 18, 20252025/0381291ANTI-CEACAM5 ANTIBODIES, ANTIBODY-DRUG CONJUGATES AND METHODS OF USES THEREOFPharmaceuticalsSeagen Inc.
Dec 18, 20252025/0381259Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses ThereofPharmaceuticalsPfizer Inc.
Dec 11, 20252025/0376530METHODS FOR TREATMENT OF INFLAMMATORY BOWEL DISEASE WITH AN ANTI-TL1A ANTIBODYPharmaceuticalsPfizer Inc.
Dec 11, 20252025/0375408COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOFPharmaceuticalsArena Pharmaceuticals, Inc.
Dec 4, 20252025/0367662SYSTEMS AND METHODS FOR PERFORMING BIOLOGICAL ASSAYS USING A THERMALLY SEALED VALVEBiotechnologyPfizer Inc.
Dec 4, 20252025/0367255Enhancement Of CD47 Blockade Therapy With Anti-VEGF AgentsPharmaceuticalsPfizer Inc.
Dec 4, 20252025/0367129Lipid Compounds and Uses ThereofOrganic fine chemistryPfizer Inc.
Nov 13, 20252025/0346567SUBSTITUTED PYRIDINE AND PHENYL COMPOUNDSOrganic fine chemistryPfizer Inc.
Nov 13, 20252025/0346560CRYSTALLINE L-ARGININE SALT OF (R)-2-(7-(4-CYCLOPENTYL-3-(TRIFLUOROMETHYL)BENZYLOXY)-1,2,3, 4-TETRAHYDROCYCLO-PENTA [B]INDOL-3-YL)ACETIC ACID(COMPOUND1) FOR USE IN SIPI RECEPTOR-ASSOCIATED DISORDERSPharmaceuticalsARENA PHARMACEUTICALS, INC.
What it applied for, 2024 to 2025: Pharmaceuticals 224 · Organic fine chemistry 51 · Biotechnology 27 · Medical technology 10 · Analysis of biological materials 4 · Chemical engineering 4.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton PFE · research, not advice